SCHEMBL565297

SCHEMBL565297

CCON(Cc1ccccc1)C[C@@H](C)C(=O)N(Cc1cc(Cl)c2c(c1)OCCCO2)CC(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PROKR2 Q8NFJ6 5/20 0.52
TSHR P16473 5/20 0.38
POLB P06746 2/20 0.38
ALDH1A1 P00352 5/20 0.35
GAA P10253 2/20 0.35
HPGD P15428 2/20 0.35
MAPT P10636 1/20 0.35
KDM4E B2RXH2 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HTT P42858 1/20 0.35
LMNA P02545 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
MAPK8 P45983 1/20 0.34
CHRM5 P08912 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL564264 1.00 PROKR2 (0.52) PROKR2TSHRPOLBALDH1A1GAA
SCHEMBL565131 0.87 PROKR2 (0.54) PROKR2TSHRPOLBALDH1A1GAA
SCHEMBL565624 0.87 PROKR2 (0.56) PROKR2TSHRPOLBALDH1A1GAA
SCHEMBL15693909 0.82 PROKR2 (0.69) PROKR2TSHRALDH1A1HPGDMAPT
SCHEMBL565109 0.82 PROKR2 (0.69) PROKR2TSHRALDH1A1HPGDMAPT
SCHEMBL565524 0.82 PROKR2 (0.69) PROKR2TSHRALDH1A1HPGDMAPT
SCHEMBL564265 0.80 PROKR2 (0.55) PROKR2TSHRPOLBALDH1A1MAPT
SCHEMBL565158 0.80 PROKR2 (0.57) PROKR2HTTNPC1RAB9AMAPK8
SCHEMBL20915071 0.80 PROKR2 (0.57) PROKR2HTTNPC1RAB9AMAPK8
SCHEMBL10119874 0.80 PROKR2 (0.56) PROKR2TSHRALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722896-B2 Prokineticin receptor antagonists and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-05-13 US disclosed
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035149-A1 Prokineticin Receptor Antagonists And Uses Thereof PROKR2, PROKR1, GIPR PROKR2 1/4885TSHR 291/4885POLB 3608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.